MoonLake Immunotherapeutics (MLTX) has a market capitalization of $1.35B and trades at $18.78. The 52-week range is 5.95-62.75.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.3, Earnings Per Share (EPS) of $-3.53.
The stock has a beta of 1.19, operates in the Healthcare sector.
